Diagnostic accuracy of three technologies for the diagnosis of multi-drug resistant tuberculosis

Diagnostic accuracy of three technologies for the diagnosis of multi-drug resistant tuberculosis

Introduction: Multi-drug resistant (MDR-TB) and extensively drug-resistant (XDR-TB) tuberculoses are a global public health problem. Their timely detection might reduce the burden of the disease and the economic impact on health systems worldwide. Objective: To conduct a literature review of the dia...

Full description

Bibliographic Details
Main Authors:	Nelson José Alvis-Zakzuk, María de los Ángeles Carrasquilla, Verónica Jhajaira Gómez, Jaime Robledo, Nelson Rafael Alvis-Guzmán, José Mauricio Hernández
Format:	Article
Language:	English
Published:	Instituto Nacional de Salud 2017-09-01
Series:	Biomédica: revista del Instituto Nacional de Salud
Subjects:	Tuberculosis extensively drug-resistant tuberculosis tuberculosis, multidrug-resistant sensitivity and specificity review
Online Access:	https://www.revistabiomedica.org/index.php/biomedica/article/view/3437

Similar Items

Multidrug-resistant tuberculosis in Lithuania – Still a long way ahead
by: Greta Musteikienė, et al.
Published: (2016-01-01)

Adverse treatment outcomes in multidrug resistant tuberculosis go beyond the microbe-drug interaction: Results of a multiple correspondence analysis.
by: Ángela Tobón, et al.
Published: (2020-12-01)

The spectrum of primary drug resistance of Mycobacterium tuberculosis in patients with tuberculosis in relation to human immunodeficiency virus status
by: V N Zimina, et al.
Published: (2017-11-01)

Extensively Drug-resistant Tuberculosis, Italy and Germany
by: Giovannittista Migliori, et al.
Published: (2007-05-01)

Can a new nitroimidazole knockout the unconquered tuberculosis?
by: Dhyuti Gupta, et al.
Published: (2020-01-01)

Comparison of the yield of tuberculosis among contacts of multidrug-resistant and drug-sensitive tuberculosis patients in Ethiopia using GeneXpert as a primary diagnostic test
by: Nebiyu Hiruy, et al.
Published: (2018-06-01)

High degree of fluoroquinolone resistance among pulmonary tuberculosis patients in New Delhi, India
by: Rohini Sharma, et al.
Published: (2019-01-01)

Bedaquiline in the multidrug-resistant tuberculosis treatment: Belarus experience
by: Alena Skrahina, et al.
Published: (2016-01-01)

Laboratory-based Surveillance of Extensively Drug-Resistant Tuberculosis, China
by: Yunfeng Deng, et al.
Published: (2011-03-01)

Programmatic challenges in managing multidrug-resistant tuberculosis in Malawi
by: Loveness Charlie, et al.
Published: (2021-01-01)

Detection of drug-resistant mycobacterium tuberculosis strains isolated in Serbia by the GenoType MTBDRsl assay
by: Živanović Irena, et al.
Published: (2012-01-01)

Multidrug-resistant tuberculosis in children and response to therapy
by: Ira Shah
Published: (2015-01-01)

Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid
by: Francesco Pecora, et al.
Published: (2021-05-01)

Emergence and Spread of Extensively and Totally Drug-Resistant Tuberculosis, South Africa
by: Marisa Klopper, et al.
Published: (2013-03-01)

Prevalencia de la resistencia de Mycobacterium tuberculosis a quinolonas y fármacos inyectables en Colombia, 2012-2013
by: Claudia Llerena, et al.
Published: (2017-01-01)

THE EFFICIENCY OF TREATMENT IN MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS REGISTERED IN 2010
by: S. A. Sterlikov, et al.
Published: (2014-03-01)

Project extension for community healthcare outcomes improves care and treatment for multidrug-resistant tuberculosis patients in Tanzania
by: Daud Dunstan Peter, et al.
Published: (2021-01-01)

A cross-sectional study about knowledge and attitudes toward multidrug-resistant and extensively drug-resistant tuberculosis in a high-burden drug-resistant country
by: Hasnain Javed, et al.
Published: (2016-01-01)

Efficacy of bedaquiline in the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis
by: Ming-Gui Wang, et al.
Published: (2021-09-01)

Challenges and Controversies in Defining Totally Drug-Resistant Tuberculosis
by: Peter Cegielski, et al.
Published: (2012-11-01)

Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014
by: Benoît Henry, et al.
Published: (2016-03-01)

Genotypic characterization of rpoB, katG and inhA gene of multi drug tuberculosis isolates from extra pulmonary tuberculosis
by: Anand Kumar Maurya, et al.
Published: (2017-01-01)

Serum zinc level and its association with multidrug-resistant tuberculosis
by: Nilima Barman, et al.
Published: (2021-01-01)

HIV Infection and Geographically Bound Transmission of Drug-Resistant Tuberculosis, Argentina
by: Viviana Ritacco, et al.
Published: (2012-11-01)

A molecular platform for the diagnosis of multidrug-resistant and pre-extensively drug-resistant tuberculosis based on single nucleotide polymorphism mutations present in Colombian isolates of Mycobacterium tuberculosis
by: Luz Maira Wintaco Martínez, et al.
Published: (2016-02-01)

Knowledge, attitude, and practices of health-care providers toward antibiotic prescribing, antibiotic resistance, and multidrug-resistant tuberculosis
by: Ashna Malhotra, et al.
Published: (2021-01-01)

Multidrug-Resistant Tuberculosis in Europe, 2010–2011
by: Gunar Günther, et al.
Published: (2015-03-01)

Predicting treatment failure risk in a Chinese Drug-Resistant Tuberculosis with surgical therapy: Development and assessment of a new predictive nomogram
by: Liwei Wu, et al.
Published: (2020-07-01)

Epidemiological profile of multidrug-resistant tuberculosis patients in Gorakhpur Division, Uttar Pradesh, India
by: U Venkatesh, et al.
Published: (2018-01-01)

Genotypic analysis of multidrug-resistant tuberculosis isolates from extra pulmonary tuberculosis cases in tertiary care centers in Northern India
by: Anand K Maurya, et al.
Published: (2016-01-01)

Determining Mycobacterium tuberculosis Drug Resistance and Risk Factors for Multidrug-Resistant Tuberculosis in Sputum Smear-Positive Tuberculosis Outpatients in Anhui Province, China, 2015–2016
by: Yao S, et al.
Published: (2020-04-01)

Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives
by: Singh A, et al.
Published: (2020-01-01)

Investigation of the comparative cost-effectiveness of different strategies for the management of multidrug-resistant tuberculosis
by: Rockcliffe, Nicole
Published: (2003)

Second-line drug susceptibilities of multidrug- and rifampicin-resistant Mycobacterium tuberculosis isolates in Delhi
by: Zeeshan Sidiq, et al.
Published: (2019-01-01)

Multidrug-resistant Tuberculosis Burden among the New Tuberculosis Patients in Zhejiang Province: An Observational Study, 2009–2013
by: Ying Peng, et al.
Published: (2017-01-01)

Molecular characterization of pyrazinamide resistance in Mycobacterium tuberculosis
by: Ko, Wai-ting, et al.
Published: (2014)

ASSOCIATION OF VITAMIN D DEFICIENCY WITH TUBERCULOSIS IN ADULT PATIENTS REPORTING TO A TERTIARY CARE HOSPITAL OF RAWALPINDI
by: Syed Fawad Mashhadi, et al.
Published: (2014-09-01)

Role of Risk Factors in the Incidence of Multidrug-Resistant Tuberculosis
by: Alya Putri Khairani, et al.
Published: (2017-09-01)

Development of a cost-effective drug sensitivity test for multi-drug resistant and extensively drug-resistant tuberculosis
by: Patel, Fadheela
Published: (2013)

Drug resistance pattern of Mycobacterium tuberculosis in the province with highest incidence of tuberculosis in Iran
by: N Mansoori, et al.
Published: (2016-01-01)